Biosurfactant-Based Interventions for Improving Lung Function and Controlling Inflammation
{"Biosurfactants":[0],"are":[1],"promising":[2,182],"biotechnological":[3],"compounds":[4,57],"for":[5,163,184],"respiratory":[6,53,90,108,194],"diseases":[7],"due":[8],"to":[9,12,24,71],"their":[10,22,96,111],"ability":[11],"act":[13],"as":[14,19,21,36,98,152,159],"antimicrobials,":[15],"antivirals,":[16],"and":[17,40,51,65,68,80,92,131,139,155,181],"anti-inflammatories,":[18],"well":[20],"capacity":[23],"reduce":[25],"pulmonary":[26,46,153],"surface":[27],"tension.":[28],"In":[29],"vitro":[30],"evidence":[31,174],"shows":[32],"that":[33,176],"molecules":[34],"such":[35,151],"surfactin,":[37],"rhamnolipids,":[38],"sophorolipids,":[39],"MELs":[41],"can":[42],"partially":[43],"mimic":[44],"natural":[45],"surfactant,":[47],"promote":[48],"alveolar":[49],"stabilization,":[50],"improve":[52],"mechanics.":[54],"Furthermore,":[55],"these":[56],"modulate":[58],"essential":[59,161],"inflammatory":[60,104,190],"pathways,":[61],"including":[62],"NF-κB,":[63],"MAPK,":[64],"inflammasomes":[66],"(NLRP3":[67],"AIM2),":[69],"leading":[70],"decreased":[72],"production":[73,119],"of":[74,106,128,134,145,173],"the":[75,107,117,125,132],"pro-inflammatory":[76],"cytokines":[77],"IL-1β,":[78],"TNF-α,":[79],"IL-6.":[81],"Activity":[82],"against":[83],"Pseudomonas":[84],"aeruginosa,":[85],"Staphylococcus":[86],"aureus,":[87],"Mycobacterium":[88],"tuberculosis,":[89],"fungi,":[91],"enveloped":[93],"viruses":[94],"support":[95],"use":[97],"therapeutic":[99],"agents":[100],"in":[101,122,141,192],"infectious":[102],"or":[103,188],"conditions":[105],"tract.":[109],"Despite":[110],"potential,":[112],"several":[113],"challenges":[114],"persist,":[115],"particularly":[116],"high":[118],"costs,":[120],"difficulties":[121],"structural":[123],"standardization,":[124],"limited":[126],"stability":[127],"inhalable":[129],"forms,":[130],"lack":[133],"clinical":[135],"trials":[136],"evaluating":[137],"safety":[138],"efficacy":[140],"humans.":[142],"The":[143],"development":[144],"more":[146],"advanced":[147],"disease":[148],"prediction":[149],"models,":[150],"organoids":[154],"\\"lung-on-a-chip\\"":[156],"systems,":[157],"emerges":[158],"an":[160,179],"path":[162],"translational":[164],"evaluation.":[165],"Thus,":[166],"although":[167],"many":[168],"obstacles":[169],"remain,":[170],"this":[171],"body":[172],"demonstrates":[175],"biosurfactants":[177],"represent":[178],"innovative":[180],"platform":[183],"improving":[185],"lung":[186],"function":[187],"modulating":[189],"processes":[191],"various":[193],"diseases.":[195]}
Authors
- Paula Rezende‐Teixeira (ORCID: https://orcid.org/0000-0003-4138-8040)
- Nathalia Marton Santana
Institutions
- Universidade de Santo Amaro (BR)
Publication Details
- Journal
- Pharmaceutical Research
- Published
- 2026-09-18
- DOI
- https://doi.org/10.1007/s11095-026-04202-4
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00